Onyx Scientific, a global small molecule CDMO, is investing more than £1.5m to expand its Good Manufacturing Practice (GMP) facilities and increase commercial active pharmaceutical ingredient (API) production at its Sunderland UK facility. The expansion will add four GMP suites, taking the total from six to ten, while increasing capacity for commercial API production and [...] The post Onyx Scientific Boosts API Manufacturing Capacity in UK first appeared on World Pharma Today .